APA

Montini E., Cesana D., Schmidt M., Sanvito F., Bartholomae C. C., Ranzani M., Benedicenti F., Sergi L. S., Ambrosi A., Ponzoni M., Doglioni C., Di Serio C., von Kalle C. & Naldini L. (20090424). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. : The Journal of clinical investigation.

Chicago

Montini Eugenio, Cesana Daniela, Schmidt Manfred, Sanvito Francesca, Bartholomae Cynthia C, Ranzani Marco, Benedicenti Fabrizio, Sergi Lucia Sergi, Ambrosi Alessandro, Ponzoni Maurilio, Doglioni Claudio, Di Serio Clelia, von Kalle Christof and Naldini Luigi. 20090424. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. : The Journal of clinical investigation.

Harvard

Montini E., Cesana D., Schmidt M., Sanvito F., Bartholomae C. C., Ranzani M., Benedicenti F., Sergi L. S., Ambrosi A., Ponzoni M., Doglioni C., Di Serio C., von Kalle C. and Naldini L. (20090424). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. : The Journal of clinical investigation.

MLA

Montini Eugenio, Cesana Daniela, Schmidt Manfred, Sanvito Francesca, Bartholomae Cynthia C, Ranzani Marco, Benedicenti Fabrizio, Sergi Lucia Sergi, Ambrosi Alessandro, Ponzoni Maurilio, Doglioni Claudio, Di Serio Clelia, von Kalle Christof and Naldini Luigi. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. : The Journal of clinical investigation. 20090424.